Literature DB >> 3549750

Sensitive analysis of blood for amodiaquine and three metabolites by high-performance liquid chromatography with electrochemical detection.

D L Mount, L C Patchen, P Nguyen-Dinh, A M Barber, I K Schwartz, F C Churchill.   

Abstract

A high-performance liquid chromatographic method using oxidative electrochemical detection has been developed for selective and sensitive quantification of the antimalarial drug amodiaquine and three of its metabolites in the blood of dosed individuals. The method requires only one extraction step and has detection limits of 1 ng/ml for amodiaquine and its metabolites desethylamodiaquine and bisdesethylamodiaquine and 3 ng/ml for 2-hydroxydesethylamodiaquine. Minor modification of the mobile phase preserves the chromatographic separation and allows ultraviolet spectroscopic detection, which, although appreciably less sensitive, permits monitoring of levels of amodiaquine and the three metabolites in blood and urine samples if an electrochemical detector is unavailable. Levels of amodiaquine and the three metabolites were determined for two volunteers undergoing a nine-week chemoprophylactic regimen in connection with travel to a malarious area. Data are included to compare the in vitro antimalarial activities against three strains of Plasmodium falciparum of amodiaquine and the three metabolites considered.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3549750     DOI: 10.1016/s0378-4347(00)83483-0

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

1.  Characterization of human cytochrome P450 mediated bioactivation of amodiaquine and its major metabolite N-desethylamodiaquine.

Authors:  Yongjie Zhang; Nico P E Vermeulen; Jan N M Commandeur
Journal:  Br J Clin Pharmacol       Date:  2016-11-16       Impact factor: 4.335

2.  The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units.

Authors:  P A Winstanley; J W Coleman; J L Maggs; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

3.  The disposition of amodiaquine in Zambians and Nigerians with malaria.

Authors:  P A Winstanley; O Simooya; J M Kofi-Ekue; O Walker; L A Salako; G Edwards; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

4.  A pilot study on quality of artesunate and amodiaquine tablets used in the fishing community of Tema, Ghana.

Authors:  Andrews O Affum; Samuel Lowor; Shiloh D Osae; Adomako Dickson; Benjamin A Gyan; Delali Tulasi
Journal:  Malar J       Date:  2013-06-28       Impact factor: 2.979

5.  Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combination.

Authors:  Muhammad Ntale; Celestino Obua; Jackson Mukonzo; Margarita Mahindi; Lars L Gustafsson; Olof Beck; Jasper W Ogwal-Okeng
Journal:  Malar J       Date:  2009-03-30       Impact factor: 2.979

Review 6.  CYP2C8 and antimalaria drug efficacy.

Authors:  J P Gil; E Gil Berglund
Journal:  Pharmacogenomics       Date:  2007-02       Impact factor: 2.533

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.